PD-L1 expression, EGFR and KRAS mutations and survival among stage III unresected non-small cell lung cancer patients: a Danish cohort study

Programmed cell death receptor ligand-1 (PD-L1) expression, KRAS (KRASm) and EGFR (EGFRm) mutations may influence non-small cell lung cancer (NSCLC) prognosis. We aimed to evaluate PD-L1 expression, KRASm, and EGFRm and survival among stage III unresected NSCLC patients. Using Danish registries, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Cronin-Fenton, Deirdre, Dalvi, Tapashi, Movva, Naimisha, Pedersen, Lars, Hansen, Hanh, Fryzek, Jon, Hedgeman, Elizabeth, Mellemgaard, Anders, Rasmussen, Torben R., Shire, Norah, Hamilton-Dutoit, Stephen, Nørgaard, Mette
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8377072/
https://www.ncbi.nlm.nih.gov/pubmed/34413420
http://dx.doi.org/10.1038/s41598-021-96486-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8377072/
https://www.ncbi.nlm.nih.gov/pubmed/34413420
http://dx.doi.org/10.1038/s41598-021-96486-2

Ejemplares similares